Animal Health Research Institute (AHRI) | Egypt
Dr. Rasha Elsabagh is a distinguished cancer immunology and stem cell researcher recognized for her extensive expertise in cancer stem cells, immunotherapy, cell-mediated immunity, and plasmonic photothermal therapy. Her work integrates immuno-oncology, stem cell biology, and bio-nanotechnology, emphasizing innovative therapeutic strategies that target tumor-infiltrating immune cells and malignant stem cell populations. Dr. Rasha Elsabagh has made significant contributions to the field through high-impact publications in journals such as Veterinary Oncology, Stem Cell Research & Therapy, Advances in Animal and Veterinary Sciences, and proceedings of the German Stem Cell Network (GSCN), highlighting her pioneering studies on Gold Nano-Rod–mediated plasmonic photothermal therapy in feline mammary carcinoma, quantitative flow cytometry assessment of feline circulatory breast cancer stem cells, and characterization of short cell-cycle duration as a defining feature of human epidermal stem cells. Her research encompasses nano-enabled cancer therapeutics, hematopoietic stem cell differentiation, tumor microenvironment modulation, and RNA-based nanoparticle delivery systems for myeloid cell reprogramming, reflecting a strong focus on translational and precision approaches to cancer treatment. Through international collaborations in Europe and the United States, she has advanced stem cell imaging, immunophenotyping, and multimodal therapeutic evaluation techniques. Dr. Rasha Elsabagh’s contributions have been recognized through competitive fellowships and awards, including a prestigious postdoctoral fellowship from France (IFE–STDF), a USAID-funded research training scholarship, and the GSCN travel award. By presenting her findings at leading international conferences and driving interdisciplinary research initiatives, she continues to advance the frontiers of immunotherapy innovation, stem cell science, and translational cancer research, establishing herself as a prominent leader in her field.
Profile: ORCID
Featured Publications
-
Elsabagh, R. H., Farghali, H. A., Emam, I. A., Abdelrahman, H., Ragab, E., Nada, A. A., & Selim, S. A. (2025). Gold nano-rod (AuNR)-mediated plasmonic photothermal therapy in feline mammary carcinoma: Assessing metastatic and nonmetastatic outcomes. Veterinary Oncology.
-
Xiao, T., Eze, U. C., Charruyer-Reinwald, A., Weisenberger, T., Khalifa, A., Abegaze, B., Schwab, G. K., Elsabagh, R. H., Parenteau, T. R., & Kochanowski, K. et al. (2024). Short cell cycle duration is a phenotype of human epidermal stem cells. Stem Cell Research and Therapy.
-
Elsabagh, R. H., Farghali, H. A. M., Emam, I. A., Abdelrahman, H., Ragab, E., Nada, A. A., & Selim, S. A. (2022). Prevention of in situ recurrence and distant metastasis in feline mammary carcinoma treated with plasmonic photothermal therapy. Research Square.
-
Elsabagh, R. H., Farghali, H. A. M., Emam, I. A., Ragab, E., Nada, A. A., & Selim, S. A. (2021). Quantitative flow cytometry assessment of feline circulatory breast cancer stem cells. Advances in Animal and Veterinary Sciences, 9(12), 2201–2215.
